The more the miserable: biotech stock woes embraced by broader market

Concerns over big retailers’ earnings triggered one of the worst sell-offs in years and dragged already battered biotech indexes down with them.

Loncar Investments CEO Brad Loncar said the latest market moves suggest the troubles that have been plaguing biotech and tech shares for more than a year are spreading to stocks across the board. He does see a glimmer of hope in some pharma shares.   ...